-transparent.png){kind=logo}
Deficiency of Antithrombin III (AT III), which is one of the main inhibitors of blood coagulation, may lead to severe thrombosis and embolism. The authors detected AT III deficiency in two patients with retinal vessel occlusion. Both patients were otherwise healthy. One had recurrent retinal vein thrombosis, the other cilioretinal occlusion. To the authors' knowledge, only one case of retinal vessel occlusion with AT III deficiency has been reported in literature. Furthermore, in the patients reported here retinal vessel occlusion may have been caused by AT III deficiency, which has considerable therapeutic and prophylactic consequences for patients with this disorder. AT III should therefore be determined in retinal vessel occlusion of unknown cause.
W D Zwierzina, and
F Kunz, and
K Miller
December 1979,
Annals of ophthalmology,
W D Zwierzina, and
F Kunz, and
K Miller
July 1999,
American journal of ophthalmology,
W D Zwierzina, and
F Kunz, and
K Miller
November 1998,
American journal of ophthalmology,
W D Zwierzina, and
F Kunz, and
K Miller
December 1995,
Journal of vascular surgery,
W D Zwierzina, and
F Kunz, and
K Miller
July 1987,
Thrombosis research,
W D Zwierzina, and
F Kunz, and
K Miller
January 2003,
Annals of cardiac anaesthesia,
W D Zwierzina, and
F Kunz, and
K Miller
January 1994,
Romanian journal of internal medicine = Revue roumaine de medecine interne,
W D Zwierzina, and
F Kunz, and
K Miller
December 1999,
Acta ophthalmologica Scandinavica,
W D Zwierzina, and
F Kunz, and
K Miller
August 1976,
The American journal of medicine,
